• P. S. Mitrou


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aversa SML, Salvagno L, Chiarion-Sileni V et al. (1995) Treatment of HlV-asso-ciated Kaposi’s sarcoma (KS). Proc ASCO 14:291Google Scholar
  2. 2.
    Bakker PJ, Danner SA, Lange JM, Veenhof KH (1988) Etoposide for epidemic Kaposi’s sarcoma: a phase II study. Eur J Cancer Clin Oncol, 24:1047–1048PubMedCrossRefGoogle Scholar
  3. 3.
    Bernstein L, Hamilton AS (1993) The epidemiology of AIDS-related malignancies. Current Op Oncol 5:822–830CrossRefGoogle Scholar
  4. 4.
    Bufill JA, Grace WR, Astrow AB (1992) Phase-II trial of prolonged low-dose oral VP-16 in AIDS related Kaposi’s sarcoma (KS). Proc ASCO 11:47Google Scholar
  5. 5.
    Cockerell C J (1991) Histopathological features of Kaposi’s sarcoma in HIV infected individuals. Cancer Surveys 10:73–89PubMedGoogle Scholar
  6. 6.
    Evans LM, Itri LM, Campion M et al. (1991) Interferon-a2a in the treatment of acquired immunodeficiency syndrome-related Kaposi’s sarcoma. J Immunother 10:39–50PubMedCrossRefGoogle Scholar
  7. 7.
    Fischl MA, Krown SE, O’Boyle KP et al. (1993) Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi’s sarcoma: J Acq Immune Def Syndromes 6:259–264Google Scholar
  8. 8.
    Foreman KE, Friborg J, Kong W-P et al. (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma. N Engl J Med 336:163–171PubMedCrossRefGoogle Scholar
  9. 9.
    Gill P, Rarick M, Bernstein-Singer M et al. (1990) Treatment of advanced Kaposi’s sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 13: 315–319PubMedCrossRefGoogle Scholar
  10. 10.
    Gill PS, Rarick MU, Mc Cutchan JA et al. (1991) Systemic treatment of AIDS-related Kaposi’s sarcoma: Results of a randomized trial. Am J Med 90:427–433PubMedGoogle Scholar
  11. 11.
    Gill PS, Wernz J, Scadden DT et al. (1995) A randomized trial of liposomal dauno-rubicin (daunoxome) versus adriamycin, bleomycin and vincristine (ABV) in 232 patients with advanced AIDS-related Kaposi’s sarcoma. Proc. ASCO 14:291Google Scholar
  12. 12.
    Gill PS, Tulpule A, Reynolds T et al. (1996) Paclitaxel (Taxol) in the treatment of relapsed or refractory advanced AIDS-related Kaposi’s sarcoma. Proc ASCO 15: 306Google Scholar
  13. 13.
    Glaspy J, Miles S, McCarthy S et al. (1986) Treatment of advanced staged Kaposi’s sarcoma with vincristine and bleomycin. Proc ASCO 5:3Google Scholar
  14. 14.
    Groopman JE, Gottlieb MS, Goodman J et al. (1984) Recombinant alpha-2 interferon therapy for Kaposi’s sarcoma associated with the acquired immunodeficiency syndrome. Ann Intern Med 100:671–676PubMedCrossRefGoogle Scholar
  15. 15.
    Guermonprez G, Katlama C, Caumes E et al. (1990) Bleomycin in the treatment of AIDS-related Kaposi’s sarcoma. Sixth Intern Conf AIDS 3:213Google Scholar
  16. 16.
    Hernandez DE, Perez JR (1996) Treatment of advanced epidemic Kaposi’s sarcoma (EKS) with bleomycin or a combination of doxorubicin, bleomycin, vincristine. Proc ASCO 15:308Google Scholar
  17. 17.
    Kaplan L, Abrams D, Volberding P (1986) Treatment of Kaposi’s sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer treat Rep 70:1121–1122PubMedGoogle Scholar
  18. 18.
    Klein E, Schwartz RA, Laor Y et al. (1980) Treatment of Kaposi’s sarcoma with vinblastine. Cancer 45:427–431PubMedCrossRefGoogle Scholar
  19. 19.
    Krigel RL, Slywotzky CM, Lonberg M et al. (1988) Treatment of epidemic Kaposi’s sarcoma with a combination of interferon-alpha 2b and etoposide. J Biol Resp Mod 7:359–364Google Scholar
  20. 20.
    Krown SE, Metroka C, Wernz JC (1989) Kaposi’s sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response and staging criteria. J Clin Oncol 7:1201–1207PubMedGoogle Scholar
  21. 21.
    Krown SE (1990) Approaches to interferon combination therapy in the treatment of AIDS. Sem Oncol 17(1, Suppl 1): 11–15Google Scholar
  22. 22.
    Krown SE, Gold JWM, Niedzwiecki D et al. (1990) Interferon-a with Zidovudine: Safety, tolerance, and clinical and virologic effect in patients with Kaposi sarcoma associated with the aquired immunodeficiency syndrome (AIDS). Ann Intern Med 112:812–821PubMedCrossRefGoogle Scholar
  23. 23.
    Lassoued K, Clauvel J-P, Katlama C et al. (1990) Treatment of the acquired immune deficiency syndrome-related Kaposi’s sarcoma with bleomycin as a single agent. Cancer 66:1869–1872PubMedCrossRefGoogle Scholar
  24. 24.
    Laubenstein LJ, Krigel RL, Odajnyk CM et al. (1984) Treatment of epidemic Kaposi’s sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115–1120PubMedGoogle Scholar
  25. 25.
    Mintzer DM, Real FX, Jovino L, Krown SE (1985) Treatment of Kaposi’s sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 102:200–202PubMedCrossRefGoogle Scholar
  26. 26.
    Mitrou PS (1996) Management of Kaposi’s sarcoma. Onkologie 19:49–52CrossRefGoogle Scholar
  27. 27.
    Mitsuyasu RT (1993) Clinical aspects of AIDS-related Kaposi’s sarcoma: Current Op Oncol 5:835–844CrossRefGoogle Scholar
  28. 28.
    Mitsuyasu RT, Gill P, Paredes J et al. (1995) Combination chemotherapy, adria-mycin, bleomycin, vincristine (ABV) with dideoxyinosine (ddl) or dideoxycytidine (ddc) in advanced AIDS-related Kaposi’s sarcoma (ACTG 163). Proc ASCO 14:289Google Scholar
  29. 29.
    Rabkin CS (1994) Epidemiology of AIDS-related malignancies. Current Op Oncol 6:492–496CrossRefGoogle Scholar
  30. 30.
    Rarick MU, Gill PS, Montgomery T et al. (1990) Treatment of epidemic Kaposi’s sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1:147–149PubMedGoogle Scholar
  31. 31.
    Real FX, Oettgen HF, Krown SE (1986) Kaposi’s sarcoma and the acquired immunodeficiency syndrome: Treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol 4:544–551PubMedGoogle Scholar
  32. 32.
    Remick SC, Reddy M, Hermann D et al. (1994) Continuous infusion bleomycin in AIDS-related Kaposi’s sarcoma. J Clin Oncol 12:1130–1136PubMedGoogle Scholar
  33. 33.
    Saville MW, Lietzau J, Pluda JM et al. (1995) Treatment of HIV-associated Kaposi’s sarcoma with paclitaxel. Lancet 346:26–28PubMedCrossRefGoogle Scholar
  34. 34.
    Volberding P, Conant MA, Strieker RB, Lewis BJ (1983) Chemotherapy in advanced Kaposi’s sarcoma. Amer J Med 74:625–656CrossRefGoogle Scholar
  35. 35.
    Volberding PA, Abrams DI, Conant M et al. (1985) Vinblastine therapy for Kaposi’s sarcoma in the acquired immune deficiency syndrome. Ann Intern Med 103: 335–338PubMedCrossRefGoogle Scholar
  36. 36.
    Volm MD, von Roenn JM (1995) Treatment strategies for epidemic Kaposi’s sarcoma. Curr Op Oncol 7:429–436CrossRefGoogle Scholar
  37. 37.
    Wernz J, Laubenstein L, Hymes K et al. (1986) Chemotherapy and assessment of response in epidemic Kaposi’s sarcoma (EKS) with bleomycin (B)/Velban (V). Proc ASCO 5:4Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • P. S. Mitrou

There are no affiliations available

Personalised recommendations